ENZYMATIC VITRECTOMY BY INTRAVITREAL AUTOLOGOUS PLASMIN INJECTION AS INITIAL TREATMENT FOR MACULAR EPIRETINAL MEMBRANES AND VITREOMACULAR TRACTION SYNDROME VITRECTOMÍA ENZIMÁTICA POR INYECCIÓN INTRAVÍTREA DE PLASMINA AUTÓLOGA COMO TRATAMIENTO INICIAL DE LAS MEMBRANAS EPIRRETINIANAS MACULARES Y EL SÍNDROME DE TRACCIÓN VITREOMACULAR

Purpose: To determine the effectiveness of intravitreal plasmin injection in the treatment of macular epiretinal membranes (MEM) and vitreomacular traction syndrome (VMTS) without associated pars plana vitrectomy. Methods: Design: Interventional, prospective, case series pilot study. Patients: Seven patients were enrolled in the study, 4 with MEM and 3 with VMTS. Treatment: 0.2 ml of autologous plasmin intravitreally injected under topical anesthesia was administered